{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T18:26:55Z","timestamp":1795199215511,"version":"4.10.3"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T00:00:00Z","timestamp":1568937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T00:00:00Z","timestamp":1568937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Insulin resistance is an important clinical feature of metabolic syndrome, which includes obesity and type 2 diabetes. Increased adipose energy storage in obesity promote insulin resistance and other metabolic adverse effects. To identify a new link between adipocyte and insulin resistance, we performed targeted metabolite profiling of differentiated adipocytes and studied the association between adipogenic metabolites and insulin resistance. We found a correlation between 2-aminoadipic acid (2-AAA) and adipogenic differentiation. Also, circulatory 2-AAA was positively associated with obesity-related factors (fat mass, fat percent, waist circumference, BMI, BMI\n                    <jats:italic>z<\/jats:italic>\n                    -score, triglycerides, insulin, and HOMA-IR) at baseline and after 2 years in the children cohort study. Of these factors, increased BMI\n                    <jats:italic>z<\/jats:italic>\n                    -score and HOMA-IR were the primary independent factors associated with higher 2-AAA levels, and the baseline 2-AAA level was an indicator of the BMI\n                    <jats:italic>z<\/jats:italic>\n                    -score after 2 years. To validate the relationship between 2-AAA and obesity-related factors, we analyzed changes in 2-AAA levels following obesity intervention programs in two independent studies. In both studies, changes in 2-AAA levels during the intervention period were positively correlated with changes in the BMI\n                    <jats:italic>z<\/jats:italic>\n                    -score and HOMA-IR after adjusting for confounders. Moreover, the 2-AAA levels were increased in cell and mouse models of obesity-related insulin resistance. Excess 2-AAA levels led to impaired insulin signaling in insulin-sensitive cells (liver, skeletal muscle and adipose cells) and caused abnormal gluconeogenesis. Our results demonstrate that 2-AAA is associated with adipogenesis and insulin resistance. In this regard, 2-AAA could be a potential biomarker of obesity and obesity-related metabolic disorders.\n                  <\/jats:p>","DOI":"10.1038\/s41598-019-49578-z","type":"journal-article","created":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T06:15:48Z","timestamp":1568960148000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["2-Aminoadipic acid (2-AAA) as a potential biomarker for insulin resistance in childhood obesity"],"prefix":"10.1038","volume":"9","author":[{"given":"Hyo Jung","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han Byul","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won-Ho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keon Jae","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwang Youl","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Ick","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye- Ja","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,20]]},"reference":[{"key":"49578_CR1","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1161\/CIRCULATIONAHA.111.047738","volume":"126","author":"R Lakshman","year":"2012","unstructured":"Lakshman, R., Elks, C. E. & Ong, K. K. Childhood obesity. Circulation. 126, 1770\u20139 (2012).","journal-title":"Circulation."},{"key":"49578_CR2","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1016\/S0140-6736(10)60171-7","volume":"375","author":"JC Han","year":"2010","unstructured":"Han, J. C., Lawlor, D. A. & Kimm, S. Y. Childhood obesity-2010: Progress and challenges. Lancet. 375, 1737\u201348 (2010).","journal-title":"Lancet."},{"key":"49578_CR3","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/nature05482","volume":"444","author":"SE Kahn","year":"2006","unstructured":"Kahn, S. E., Hull, R. L. & Utzschneider, K. M. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature. 444, 840\u20136 (2006).","journal-title":"Nature."},{"key":"49578_CR4","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1172\/JCI10583","volume":"106","author":"GI Shulman","year":"2000","unstructured":"Shulman, G. I. Cellular mechanisms of insulin resistance. J Clin. Invest. 106, 171\u20136 (2000).","journal-title":"J Clin. Invest."},{"key":"49578_CR5","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nm0106-41","volume":"12","author":"C de Luca","year":"2006","unstructured":"de Luca, C. & Olefsky, J. M. Stressed out about obesity and insulin resistance. Nat. Med. 12, 41\u20132 (2006).","journal-title":"Nat. Med."},{"key":"49578_CR6","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.cmet.2009.02.002","volume":"9","author":"CB Newgard","year":"2009","unstructured":"Newgard, C. B. et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab. 9, 311\u201326 (2009).","journal-title":"Cell Metab."},{"key":"49578_CR7","doi-asserted-by":"publisher","unstructured":"Kimberly, W. T. et al. Metabolite profiling identifies anandamide as a biomarker of nonalcoholic steatohepatitis. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.92989 (2017).","DOI":"10.1172\/jci.insight.92989"},{"key":"49578_CR8","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.ijcard.2008.12.131","volume":"142","author":"F Perticone","year":"2010","unstructured":"Perticone, F. et al. Endothelial dysfunction, ADMA and insulin resistance in essential hypertension. Int. J. Cardiol. 142, 236\u201341 (2010).","journal-title":"Int. J. Cardiol."},{"key":"49578_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-20549-0","volume":"8","author":"W Lee","year":"2018","unstructured":"Lee, W. et al. Asymmetric dimethylarginine (ADMA) is identified as a potential biomarker of insulin resistance in skeletal muscle. Sci. Rep. 8, 2133 (2018).","journal-title":"Sci. Rep."},{"key":"49578_CR10","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1373\/clinchem.2015.250761","volume":"62","author":"GF Svingen","year":"2016","unstructured":"Svingen, G. F. et al. Prospective associations of systemic and urinary choline metabolites with incident type 2 diabetes. Clin. Chem. 62, 755\u201365 (2016).","journal-title":"Clin. Chem."},{"key":"49578_CR11","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1073\/pnas.98.1.69","volume":"98","author":"JR Requena","year":"2001","unstructured":"Requena, J. R., Chao, C. C., Levine, R. L. & Stadtman, E. R. Glutamic and aminoadipic semialdehydes are the main carbonyl products of metal-catalyzed oxidation of proteins. Proc. Natl. Acad. Sci. USA 98, 69\u201374 (2001).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"49578_CR12","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1021\/pr100121k","volume":"9","author":"H Tsutsui","year":"2010","unstructured":"Tsutsui, H. et al. Practical analytical approach for the identification of biomarker candidates in prediabetic state based upon metabonomic study by ultraperformance liquid chromatography coupled to electrospray ionization time-of-flight mass spectrometry. J Proteome Res. 9, 3912\u201322 (2010).","journal-title":"J Proteome Res."},{"key":"49578_CR13","doi-asserted-by":"publisher","first-page":"5451","DOI":"10.1046\/j.1432-1033.2002.03243.x","volume":"269","author":"M Akagawa","year":"2002","unstructured":"Akagawa, M., Sasaki, T. & Suyama, K. Oxidative deamination of lysine residue in plasma protein of diabetic rats: Novel mechanism via the Maillard reaction. Eur. J. Biochem. 269, 5451\u20138 (2002).","journal-title":"Eur. J. Biochem."},{"key":"49578_CR14","doi-asserted-by":"publisher","first-page":"4309","DOI":"10.1172\/JCI64801","volume":"123","author":"TJ Wang","year":"2013","unstructured":"Wang, T. J. et al. 2-Aminoadipic acid is a biomarker for diabetes risk. J. Clin. Invest. 123, 4309\u201317 (2013).","journal-title":"J. Clin. Invest."},{"key":"49578_CR15","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S1043-2760(00)00323-4","volume":"11","author":"RN Bergman","year":"2000","unstructured":"Bergman, R. N. & Ader, M. Free fatty acids and pathogenesis of type 2 diabetes mellitus. Trends Endocrinol. Metab. 11, 351\u20136 (2000).","journal-title":"Trends Endocrinol. Metab."},{"key":"49578_CR16","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.cmet.2009.11.008","volume":"11","author":"KL Hoehn","year":"2010","unstructured":"Hoehn, K. L. et al. Acute or chronic upregulation of mitochondrial fatty acid oxidation has no net effect on whole body energy expenditure or adiposity. Cell Metab. 11, 70\u20136 (2010).","journal-title":"Cell Metab."},{"key":"49578_CR17","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.tem.2011.12.008","volume":"23","author":"KH Fisher-Wellman","year":"2012","unstructured":"Fisher-Wellman, K. H. & Neufer, P. D. Linking mitochondrial bioenergetics to insulin resistance via redox biology. Trends Endocrinol. Metab. 23, 142\u201353 (2012).","journal-title":"Trends Endocrinol. Metab."},{"key":"49578_CR18","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.celrep.2012.04.006","volume":"1","author":"M Van Beek","year":"2012","unstructured":"Van Beek, M. et al. Bcl10 links saturated fat overnutrition with hepatocellular NF-\u03baB activation and insulin resistance. Cell Rep. 1, 444\u201352 (2012).","journal-title":"Cell Rep."},{"key":"49578_CR19","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.cellsig.2008.10.004","volume":"21","author":"JH Lim","year":"2009","unstructured":"Lim, J. H., Lee, H. J., Ho Jung, M. & Song, J. Coupling mitochondrial dysfunction to endoplasmic reticulum stress response: a molecular mechanism leading to hepatic insulin resistance. Cell Signal. 21, 169\u201377 (2009).","journal-title":"Cell Signal."},{"key":"49578_CR20","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1152\/physrev.00033.2011","volume":"93","author":"A Tchernof","year":"2013","unstructured":"Tchernof, A. & Despres, J. P. Pathophysiology of human visceral obesity: An update. Physiol. Rev. 93, 359\u2013404 (2013).","journal-title":"Physiol. Rev."},{"key":"49578_CR21","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.tem.2015.01.006","volume":"26","author":"B Gustafson","year":"2015","unstructured":"Gustafson, B., Hediazifar, S., Gogg, S., Hammarstedt, A. & Smith, U. Insulin resistance and impaired adipogenesis. Trends Endocrinol. Metab. 26, 193\u2013200 (2015).","journal-title":"Trends Endocrinol. Metab."},{"key":"49578_CR22","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.cmet.2013.03.008","volume":"17","author":"T Tchkonia","year":"2013","unstructured":"Tchkonia, T. et al. Mechanisms and metabolic implications of regional differences among fat depots. Cell Metab. 17, 644\u2013656 (2013).","journal-title":"Cell Metab."},{"issue":"Suppl. 4","key":"49578_CR23","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1038\/sj.ijo.0802853","volume":"28","author":"L Heilbronn","year":"2004","unstructured":"Heilbronn, L., Smith, S. R. & Ravussin, E. Failure of fat cell proliferation, mitochondrial function and fat oxidation results in ectopic fat storage, insulin resistance and type II diabetes mellitus. Int. J. Obes. Relat. Metab. Disord. 28(Suppl. 4), S12\u201321 (2004).","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"49578_CR24","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1053\/j.gastro.2016.12.051","volume":"152","author":"S Caprio","year":"2017","unstructured":"Caprio, S., Perry, R. & Kursawe, R. Adolescent obesity and insulin resistance: Roles of ectopic fat accumulation and adipose inflammation. Gastroenterology. 152, 1638\u20131646 (2017).","journal-title":"Gastroenterology."},{"key":"49578_CR25","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1042\/BJ20061645","volume":"404","author":"DR Sell","year":"2007","unstructured":"Sell, D. R., Strauch, C. M., Shen, W. & Monnier, V. M. 2-Aminoadipic acid is a marker of protein carbonyl oxidation in the aging human skin: Effects of diabetes, renal failure and sepsis. Biochem. J. 404, 269\u201377 (2007).","journal-title":"Biochem. J."},{"key":"49578_CR26","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.cmet.2012.01.024","volume":"15","author":"CB Newgard","year":"2012","unstructured":"Newgard, C. B. Interplay between lipid and branched-chain amino acids in development of insulin resistance. Cell Metab. 15, 606\u201314 (2012).","journal-title":"Cell Metab."},{"key":"49578_CR27","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1210\/jc.2017-02114","volume":"103","author":"F Ottosson","year":"2018","unstructured":"Ottosson, F. et al. Connection between BMI related plasma metabolite profile and gut microbiota. J Clin. Endocrinol. Metab. 103, 1491\u20131501 (2018).","journal-title":"J Clin. Endocrinol. Metab."},{"key":"49578_CR28","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1093\/ajcn\/62.3.564","volume":"62","author":"J Ma","year":"1995","unstructured":"Ma, J., Folsom, A. R., Shahar, E. & Eckfeldt, J. H. Plasma fatty acid composition as an indicator of habitual dietary fat intake in middle-aged adults: The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Am. J. Clin. Nutr. 62, 564\u201371 (1995).","journal-title":"Am. J. Clin. Nutr."},{"key":"49578_CR29","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.2337\/dc09-2310","volume":"33","author":"TN Kim","year":"2010","unstructured":"Kim, T. N. et al. Prevalence and determinant factors of sarcopenia in patients with type 2 diabetes: The Korean Sarcopenic Obesity Study (KSOS). Diabetes Care. 33, 1497\u20139 (2010).","journal-title":"Diabetes Care."},{"key":"49578_CR30","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1097\/00041433-200302000-00004","volume":"14","author":"B Vessby","year":"2003","unstructured":"Vessby, B. Dietary fat, fatty acid composition in plasma and the metabolic syndrome. Curr. Opin. Lipidol. 14, 15\u20139 (2003).","journal-title":"Curr. Opin. Lipidol."},{"key":"49578_CR31","unstructured":"Korean Center for Disease Control and Prevention. 2007 Korean children and adolescent growth standard. Seoul, Korea: Division of chronic disease surveillance (2007)."},{"key":"49578_CR32","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews, D. R. et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412\u20139 (1985).","journal-title":"Diabetologia"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-49578-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-49578-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-49578-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T08:48:40Z","timestamp":1671266920000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-49578-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,20]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["49578"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-49578-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,20]]},"assertion":[{"value":"24 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"13610"}}